Insider filing · ANIP
Stephen P. Carey
SVP & CFO
profile →
ANI Pharmaceuticals, Inc.
ANIP · Healthcare · 47 filings in 24 months
ticker →
Stephen P. Carey sold $418K of ANI Pharmaceuticals (ANIP)
Executed Dec 17 2024, disclosed Dec 18 2024, 1 day later.
Value, as filed
$418K
7,500 sh × $55.79
Executed
Dec 17 2024
the trade date, as filed
Disclosed
Dec 18 2024
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SCStephen P. Carey (SVP & CFO) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $552K of ANIP (7,312 sh across 2 lots, as filed), executed Mar 5.
The name
ANIPHealthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Stephen P. Carey in ANIP
ANIPSALE
ANI Pharmaceuticals, Inc.
$207K2,850 sh × $72.80
Exec Aug 31
Filed Sep 1 · 6:18 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $232K
2,850 sh × $81.36
Exec Jul 29
Filed Jul 30 · 4:02 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $285K
3,313 sh × $86.00
Exec Jul 2
Filed Jul 6 · 9:40 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $240K
2,850 sh × $84.12
Exec Jun 29
Filed Jun 30 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $265K
3,312 sh × $80.00
Exec Jun 5
Filed Jun 9 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $552K
7,312 sh across 2 lots
Exec Mar 5
Filed Mar 5 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $4.3M
50,000 sh × $86.07
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET